英国のデータではワクチン未接種者の重症化率がアルファ型の2倍と言われている新しい変異型デルタによる重症者の増加予測を、デルタ型の感染が起きていない日本の過去のデータから検証できるという根拠は何でしょうか? https://t.co/ze2UH9PKCg
— kazukazu88 (@kazukazu881) July 8, 2021
Delta variant impact on hospitalisation revealed
Vaccinations
Vaccines were found to reduce the risk of being admitted to hospital, but strong protective effects against the Delta variant were not seen until at least 28 days after the first vaccine dose.
In community cases at least two weeks after the second dose, the Pfizer-BioNTech vaccine was found to provide 79 per cent protection against infection from the Delta variant, compared with 92 per cent against the Alpha variant.
For the same scenario, the Oxford-AstraZeneca vaccine offered 60 per cent protection against infection with the Delta variant compared with 73 per cent for the Alpha variant. This lower vaccine effect may reflect that is takes longer to develop immunity with Oxford-AstraZeneca, experts say.
一回目の接種から28日後は効果がでてくるわけかあ。
で、デルタ型に対してはファイザー79% アストラ60%の予防率 つまりアストラでも効果はでている。
Vaccines highly effective against hospitalisation from Delta variant
the Pfizer-BioNTech vaccine is 96% effective against hospitalisation after 2 doses
the Oxford-AstraZeneca vaccine is 92% effective against hospitalisation after 2 doses
重症化率というのか入院化率というのか、ファイザーは96%有効 アストラでも92%有効・・・・
・・ワクチン接種が遅れて失う命もあるんだろうな、これから。
無能な大臣をもつと日本も不幸だなああ。
0 件のコメント:
コメントを投稿